These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6136644)

  • 1. Jejunal function and pathology in visceral Leishmaniasis.
    Muigai R; Gatei DG; Shaunak S; Wozniak A; Bryceson AD
    Lancet; 1983 Aug; 2(8348):476-9. PubMed ID: 6136644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electron microscopy of Leishmania donovani in splenic aspirates from patients with visceral leishmaniasis during treatment with sodium stibogluconate.
    Chulay JD; Fawcett DW; Chunge CN
    Ann Trop Med Parasitol; 1985 Aug; 79(4):417-29. PubMed ID: 3000304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Jejunal biopsy findings, mucosal dehydrogenase activity, and intestinal absorption in patients with complications after partial gastrectomies.
    Burhol PG; Myren J
    Scand J Gastroenterol; 1966; 1(4):314-23. PubMed ID: 5966090
    [No Abstract]   [Full Text] [Related]  

  • 4. [Jejunal biopsy findings and absorption of D-xylose and vitamin-A in patients with gastrointestinal diseases].
    Burhol PG; Myren J
    Tidsskr Nor Laegeforen; 1967 Jul; 87(14):1262-8. PubMed ID: 6046770
    [No Abstract]   [Full Text] [Related]  

  • 5. Stibogluconate for leishmaniasis.
    Misbahuddin M; Jahan K; Chowdhury MA; Absar N
    Lancet; 1993 Sep; 342(8874):804. PubMed ID: 8103890
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of visceral leishmaniasis in children].
    Minodier P; Noël G; Blanc P; Uters M; Retornaz K; Garnier JM
    Med Trop (Mars); 2007 Feb; 67(1):73-8. PubMed ID: 17506279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of correlation between jejunal mucosal morphology and intestinal absorption in the hepatosplenic form of schistosomiasis mansoni.
    Penna FJ; Brasileiro Filho G
    Arq Gastroenterol; 1988; 25(4):224-8. PubMed ID: 3151753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Visceral leishmaniasis with gastrointestinal involvement in a 30-year-old HIV infected patient].
    Jablonowski H; Szelényi H; Borchard F; Döhring-Schwerdtfeger E; Hengels KJ
    Z Gastroenterol; 1994 Jul; 32(7):405-7. PubMed ID: 7975778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of visceral leishmaniasis in Kenya by aminosidine alone or combined with sodium stibogluconate.
    Chunge CN; Owate J; Pamba HO; Donno L
    Trans R Soc Trop Med Hyg; 1990; 84(2):221-5. PubMed ID: 2167522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of visceral leishmaniasis using sodium stibogluconate in a dose of 15 mg antimony/kg body weight twice daily for 30 days: a preliminary report.
    Chunge CN; Gachihi G; Mugambi M; Chulay JD; Spencer HC
    East Afr Med J; 1984 Jul; 61(7):570-4. PubMed ID: 6100588
    [No Abstract]   [Full Text] [Related]  

  • 11. Electrocardiographic changes during treatment of leishmaniasis with pentavalent antimony (sodium stibogluconate).
    Chulay JD; Spencer HC; Mugambi M
    Am J Trop Med Hyg; 1985 Jul; 34(4):702-9. PubMed ID: 2992303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visceral leishmaniasis in the BALB/c mouse: antimony tissue disposition and parasite suppression after the administration of free stibogluconate.
    Collins M; Carter KC; Baillie AJ
    Ann Trop Med Parasitol; 1992 Feb; 86(1):35-40. PubMed ID: 1319700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Host peroxisomal properties are not restored to normal after treatment of visceral leishmaniasis with sodium antimony gluconate.
    Gupta S; Raychaudhury B; Datta SC
    Exp Parasitol; 2009 Oct; 123(2):140-5. PubMed ID: 19545565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiological, clinical & pharmacological study of antimony-resistant visceral leishmaniasis in Bihar, India.
    Thakur CP; Narayan S; Ranjan A
    Indian J Med Res; 2004 Sep; 120(3):166-72. PubMed ID: 15489554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The treatment of kala-azar in the Sudan with sodium stibogluconate: a randomized trial of three dosage regimens.
    Zijlstra EE; Siddig Ali M; el-Hassan AM; Hofland HW; el-Toum I; Satti M; Ghalib HW
    Trans R Soc Trop Med Hyg; 1993; 87(3):307-9. PubMed ID: 8236402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visceral leishmaniasis unresponsive to antimonial drugs. III. Successful treatment using a combination of sodium stibogluconate plus allopurinol.
    Chunge CN; Gachihi G; Muigai R; Wasunna K; Rashid JR; Chulay JD; Anabwani G; Oster CN; Bryceson AD
    Trans R Soc Trop Med Hyg; 1985; 79(5):715-8. PubMed ID: 3006296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Intestinal absorption of vitamin E in children with atrophy of the jejunal mucosa].
    Lubrano R; Lucidi V; Belli A; Cardilli V; Mannarino O; Panseri C; Strappini PM; Castro M; Giardini O
    Minerva Pediatr; 1990 Dec; 42(12):537-9. PubMed ID: 2087227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sodium stibogluconate-sensitive visceral leishmaniasis in the non-endemic hilly region of Uttarakhand, India.
    Verma SK; Ahmad S; Shirazi N; Kusum A; Kaushik RM; Barthwal SP
    Trans R Soc Trop Med Hyg; 2007 Jul; 101(7):730-2. PubMed ID: 17382981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved screening for intestinal villous atrophy by D-xylose breath test.
    Casellas F; de Torres I; Malagelada JR
    Dig Dis Sci; 2000 Jan; 45(1):18-22. PubMed ID: 10695607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antimony content of the thyroid of man and animals undergoing visceral leishmaniasis treatment with the organic compound of antimony, stibogluconate sodium].
    Fuzaĭlov IuM
    Med Parazitol (Mosk); 1982; 51(1):62-5. PubMed ID: 6278277
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.